264 related articles for article (PubMed ID: 14716691)
1. Prospects for antiviral ribozymes and deoxyribozymes.
Peracchi A
Rev Med Virol; 2004; 14(1):47-64. PubMed ID: 14716691
[TBL] [Abstract][Full Text] [Related]
2. Catalytic DNA (deoxyribozymes) for synthetic applications-current abilities and future prospects.
Silverman SK
Chem Commun (Camb); 2008 Aug; (30):3467-85. PubMed ID: 18654692
[TBL] [Abstract][Full Text] [Related]
3. Design and anti-HIV-1 activity of ribozymes that cleave HIV-1 LTR.
Koizumi M; Ozawa Y; Yagi R; Nishigaki T; Kaneko M; Oka S; Kimura S; Iwamoto A; Komatsu Y; Ohtsuka E
Nucleic Acids Symp Ser; 1995; (34):125-6. PubMed ID: 8841584
[TBL] [Abstract][Full Text] [Related]
4. Cleavage of intracellular hepatitis C RNA in the virus core protein coding region by deoxyribozymes.
Trepanier J; Tanner JE; Momparler RL; Le ON; Alvarez F; Alfieri C
J Viral Hepat; 2006 Feb; 13(2):131-8. PubMed ID: 16436131
[TBL] [Abstract][Full Text] [Related]
5. Expanding the catalytic repertoire of ribozymes and deoxyribozymes beyond RNA substrates.
Franzen S
Curr Opin Mol Ther; 2010 Apr; 12(2):223-32. PubMed ID: 20373266
[TBL] [Abstract][Full Text] [Related]
6. Gaining target access for deoxyribozymes.
Schubert S; Fürste JP; Werk D; Grunert HP; Zeichhardt H; Erdmann VA; Kurreck J
J Mol Biol; 2004 May; 339(2):355-63. PubMed ID: 15136038
[TBL] [Abstract][Full Text] [Related]
7. In vitro-selected RNA cleaving DNA enzymes from a combinatorial library are potent inhibitors of HIV-1 gene expression.
Sriram B; Banerjea AC
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):667-73. PubMed ID: 11104672
[TBL] [Abstract][Full Text] [Related]
8. The application of ribozymes to HIV infection.
Rossi JJ
Curr Opin Mol Ther; 1999 Jun; 1(3):316-22. PubMed ID: 11713796
[TBL] [Abstract][Full Text] [Related]
9. High-Throughput Analysis and Engineering of Ribozymes and Deoxyribozymes by Sequencing.
Yokobayashi Y
Acc Chem Res; 2020 Dec; 53(12):2903-2912. PubMed ID: 33164502
[TBL] [Abstract][Full Text] [Related]
10. DNAzymes as potential therapeutic molecules.
Isaka Y
Curr Opin Mol Ther; 2007 Apr; 9(2):132-6. PubMed ID: 17458166
[TBL] [Abstract][Full Text] [Related]
11. Ribozyme: a clinical tool.
Khan AU
Clin Chim Acta; 2006 May; 367(1-2):20-7. PubMed ID: 16426595
[TBL] [Abstract][Full Text] [Related]
12. In vitro selected RNA-cleaving DNA enzymes from combinatorial libraries.
Chakraborti S; Sriram B; Banerjea AC
Methods Mol Biol; 2004; 252():279-90. PubMed ID: 15017057
[TBL] [Abstract][Full Text] [Related]
13. Hammerhead ribozymes: biochemical and chemical considerations.
Goodchild J
Curr Opin Mol Ther; 2000 Jun; 2(3):272-81. PubMed ID: 11249621
[TBL] [Abstract][Full Text] [Related]
14. Ribozymes: structure, characteristics and use as potential antiviral agents.
Bartolomé J; Madejón A; Carreño V
J Hepatol; 1995; 22(1 Suppl):57-64. PubMed ID: 7602079
[TBL] [Abstract][Full Text] [Related]
15. Catalytic nucleic acids: from lab to applications.
Sun LQ; Cairns MJ; Saravolac EG; Baker A; Gerlach WL
Pharmacol Rev; 2000 Sep; 52(3):325-47. PubMed ID: 10977866
[TBL] [Abstract][Full Text] [Related]
16. Deoxyribozymes: DNA catalysts for bioorganic chemistry.
Silverman SK
Org Biomol Chem; 2004 Oct; 2(19):2701-6. PubMed ID: 15455136
[TBL] [Abstract][Full Text] [Related]
17. Revitalization of six abandoned catalytic DNA species reveals a common three-way junction framework and diverse catalytic cores.
Chiuman W; Li Y
J Mol Biol; 2006 Mar; 357(3):748-54. PubMed ID: 16480741
[TBL] [Abstract][Full Text] [Related]
18. Efficient RNA ligation by reverse-joined hairpin ribozymes and engineering of twin ribozymes consisting of conventional and reverse-joined hairpin ribozyme units.
Ivanov SA; Vauléon S; Müller S
FEBS J; 2005 Sep; 272(17):4464-74. PubMed ID: 16128815
[TBL] [Abstract][Full Text] [Related]
19. [Activity of specific deoxyribozymes to cleave hepatitis C virus RNA in vitro].
Yu YC; Gu CH; Wang SQ; Mao Q; Chen ZB; Liu HL
Zhonghua Gan Zang Bing Za Zhi; 2003 Mar; 11(3):156-8. PubMed ID: 12681063
[TBL] [Abstract][Full Text] [Related]
20. Ribozymes as antiviral agents.
Bartolomé J; Castillo I; Carreño V
Minerva Med; 2004 Feb; 95(1):11-24. PubMed ID: 15041923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
